FISV Earnings Predictions — 2026-08-06

Ticker Report or Guide KPI Prediction Answer Confidence
FISV Report Adjusted EPS (Q2 2026) BEAT pred ~$1.94 vs. cons ~$1.90 MEDIUM
FISV Report Adjusted Revenue (Q2 2026) IN-LINE pred ~$5.07B vs. cons ~$5.10B MEDIUM
FISV Report Adjusted Operating Margin (Q2 2026) MISS pred ~30.5% vs. cons ~31.0% LOW
FISV Guide FY2026 Adjusted EPS guidance UNCHANGED guide ~$8.15 vs. cons ~$8.15 (FY2026, midpoint of reaffirmed $8.00-$8.30 range) HIGH
FISV Guide FY2026 Organic Revenue Growth guidance UNCHANGED guide ~2% vs. cons ~2% (FY2026, midpoint of reaffirmed 1%-3% range) HIGH
FISV Guide Q3 2026 Organic Revenue Growth (post-trough inflection) UNCHANGED guide ~-1% vs. cons ~-1% (Q3 2026, easing from Q2's ~-3% trough per management commentary) MEDIUM
FISV Guide H2 2026 Adjusted Operating Margin ramp LOWER guide ~35% vs. cons ~35.5% (H2 2026, risk skewed to soft-pedal given Q2 margin pressure and slower Financial Solutions recovery) LOW
FISV Guide STAR/Accel debit network sale process / Jana portfolio review UNKNOWN guide ~0 (no formal update expected) vs. cons ~0 (2026, qualitative commentary only, no numeric guide) LOW
FISV Return Day-1 residual (stock − beta × S&P 500) +2.5% LOW
FISV Return 5-day cumulative residual -1.0% (FADE) An in-line-to-slightly-better Q2 vs. a heavily de-risked bar (stock already +15% off June lows, +9% in the week pre-print) likely produces a modest relief pop, but the reaffirmed FY26 guide implicitly demands a steep H2 ramp (margin from ~30-31% to 35-36%, Financial Solutions flipping from mid-single-digit decline to flat, Clover sustaining low-double-digit growth) that sell-side will immediately flag as the next hurdle. Absent a firm STAR/Accel sale announcement or concrete answer to Jana's portfolio-review demand, skepticism about out-quarter achievability, unresolved CEO-transition execution risk, and lack of a hard catalyst should erode the initial pop over the following days, consistent with a fade rather than follow-through. LOW